期刊
JOURNAL OF CONTROLLED RELEASE
卷 335, 期 -, 页码 320-332出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2021.05.036
关键词
Cancer immunotherapy; Mitochondrial dynamics; Immunosuppressive tumor microenvironment; Tumor associated macrophages; Immunogenic cell death
资金
- Natural Science Foundation of Liaoning Province [2020MS192]
- National Natural Science Foundation of China [81872820, 82073797]
- Returnees Foundation from Shenyang Pharmaceutical University [GGJJ2018103]
The development of twin-like charge-switchable nanoparticles provides a selective delivery system for targeting tumor-associated macrophages and cancer cells, reversing the immunosuppressive tumor microenvironment and enhancing the effectiveness of cancer immunotherapy.
Cancer immunotherapy has emerged as a promising option for various malignant tumors therapy. Unfortunately, the existence of an immunosuppressive tumor microenvironment (ITM) and the absence of an effective delivery strategy limit its further application. To reverse the ITM and exploit a favorable delivery system for cancer immunotherapy, twin-like charge-switchable nanoparticles (shMFN1-NPs + DOX-NPs, termed as MIX-NPs) were developed to selectively target tumor-associated macrophages (TAMs) and cancer cells, respectively. The shMFN1-NPs (150 nm) and DOX-NPs (160 nm) both had uniform spherical-shaped structures and showed favorable tumor tissue accumulation. Based on the pH-responsive core-shell separation, the nanoparticles obtained an excellent balance between the circulation time and cellular uptake. Mitochondrial dynamics are involved in macrophage polarization by regulating a novel signaling network, involving the modulation from fusion (M2-TAMs) to mitochondrial fission (M1-TAMs). M2-TAMs targeting nanoparticles shMFN1-NPs were fabricated to deliver shMFN1 for repolarization of TAMs from the M2 to M1 phenotype by inhibiting mitochondrial fusion. Moreover, DOX-NPs effectively triggered the immunogenic cell death (ICD) of cancer cells, and the succeeding maturation of dendritic cells (DCs) promoted the infiltration and activation of CD8+ T cells. MIXNPs displayed the strongest antitumor efficacy (TIR = 83%) in the subcutaneous 4T1 tumor model. MIX-NPs suppressed the myeloid-derived suppressor cells (MDSCs) and regulatory T lymphocytes (Tregs) to further remodel the ITM. Taken together, our developed drug delivery strategy reversed the ITM and activated the antitumor immune response, providing a profound prospective treatment strategy in cancer immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据